Tao Brendan K, Wong Madeleine, Shunmugam Maheshver, Bhalla Mahadev, Ling Jennifer, Gill Kulbir, Schendel Steven, Gregory-Evans Kevin, Navajas Eduardo V
Department of Ophthalmology & Vision Science, University of Toronto, Toronto.
Faculty of Health Sciences, Queens University, Kingston, ON.
J Glaucoma. 2025 Jul 1;34(7):549-554. doi: 10.1097/IJG.0000000000002570. Epub 2025 Mar 21.
Low certainty evidence suggests elevated angle closure glaucoma incidence [1.30% 95% CI (0.71-2.36)] with retinitis pigmentosa than without [risk ratio: 2.01, 95% CI (1.59-2.53)]. RP patients may benefit from enhanced monitoring for glaucomatous complications.
To determine the literature-pooled rate and association of angle closure glaucoma (ACG) with retinitis pigmentosa (RP). ACG is a potentially sight-threatening cause of optic neuropathy. To date, several reports have documented the potential association between ACG and RP.
Cochrane Library, Embase, and Medline were searched to August 2024. We included all studies that reported the incidence of ACG among patients with RP, or the comparative risk of ACG among patients with or without RP. Two independent reviewers completed study screening, data extraction, and risk of bias assessment using the Cochrane risk of bias (ROB) in nonrandomized studies (exposure) tool. Non-pairwise and pairwise meta-analyses, using random effects and the Mantel-Haenszel method, were conducted to calculate the pooled rate of ACG in RP patients and to determine whether this risk differed significantly from patients without RP. Subgroup analysis excluded "high" ROB studies.
Eight observational studies (n=31,501 patients; 456 events) were identified, 3 of which were of comparative design. Of this pooled population, there were 29,363 patients with RP (238 events). Across all studies, the pooled incidence of ACG with RP was 1.30% [95% CI (0.71-2.36), I2 : 97%], although this heterogeneity resolved when subgrouped by studies with low ROB [1.59%, 95% CI (1.31-0.192), I2 : 0%]. In the comparative analysis, patients with RP had a significantly higher risk of developing ACG [RR: 2.02, 95% CI (1.61-2.55), I2 : 0%] compared with patients without RP. For either outcome, there was no significant evidence of publication bias, and the results remained consistent across subgroup and sensitivity analyses. Six of 8 studies were rated as having "high" ROB due to a lack of adjusted analyses.
Low certainty evidence suggests that RP may confer an increased risk of ACG compared with patients without RP. The results of this study seem to support the view that more extensive clinical monitoring for ACG may be of benefit for patients with RP. Further studies controlling for individual patient-level confounding are needed.
低确定性证据表明,与无色素性视网膜炎的患者相比,色素性视网膜炎患者发生闭角型青光眼的发病率升高[1.30%,95%置信区间(0.71 - 2.36)]。色素性视网膜炎患者可能受益于加强对青光眼并发症的监测。
确定闭角型青光眼(ACG)与色素性视网膜炎(RP)的文献汇总发生率及关联。ACG是一种潜在威胁视力的视神经病变原因。迄今为止,已有多篇报告记录了ACG与RP之间的潜在关联。
检索至2024年8月的Cochrane图书馆、Embase和Medline。我们纳入了所有报告色素性视网膜炎患者中ACG发病率,或有或无色素性视网膜炎患者中ACG比较风险的研究。两名独立审阅者使用非随机研究(暴露)工具中的Cochrane偏倚风险(ROB)完成研究筛选、数据提取和偏倚风险评估。采用随机效应和Mantel - Haenszel方法进行非成对和成对荟萃分析,以计算色素性视网膜炎患者中ACG的汇总发生率,并确定该风险与无色素性视网膜炎患者相比是否有显著差异。亚组分析排除了“高”ROB研究。
共识别出8项观察性研究(n = 31,501例患者;456例事件),其中3项为比较设计。在这个汇总人群中,有29,363例色素性视网膜炎患者(238例事件)。在所有研究中,色素性视网膜炎患者中ACG的汇总发生率为1.30%[95%置信区间(0.71 - 2.36),I²:97%],不过按低ROB研究进行亚组分析时这种异质性消失了[1.59%,95%置信区间(1.31 - 0.‘192’),I²:0%]。在比较分析中,与无色素性视网膜炎的患者相比,色素性视网膜炎患者发生ACG的风险显著更高[风险比:2.02,95%置信区间(1.61 - 2.55),I²:0%]。对于任何一种结果,均无显著的发表偏倚证据,且结果在亚组分析和敏感性分析中保持一致。8项研究中有6项因缺乏调整分析而被评为“高”ROB。
低确定性证据表明,与无色素性视网膜炎的患者相比,色素性视网膜炎可能使ACG风险增加。本研究结果似乎支持这样一种观点,即对色素性视网膜炎患者进行更广泛的ACG临床监测可能有益。需要进一步开展控制个体患者层面混杂因素的研究。